Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-613M10.8 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | RNF219 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | MRPL50 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | RNF126 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | TRA2B | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | CRIM1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | PRIMPOL | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | NAA15 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | SRPK1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |